Ampio Pharmaceuticals, Inc.
AMPE
$0.01
-$0.14-96.39%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.08M | 8.07M | 9.97M | 12.00M | 11.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.52M | 10.00M | 14.33M | 17.75M | 20.38M |
| Operating Income | -9.52M | -10.00M | -14.33M | -17.75M | -20.38M |
| Income Before Tax | -8.63M | -8.80M | -13.98M | -14.68M | -16.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.63 | -8.80 | -13.98 | -14.68 | -16.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.63M | -8.80M | -13.98M | -14.68M | -16.34M |
| EBIT | -9.52M | -10.00M | -14.33M | -17.75M | -20.38M |
| EBITDA | -9.39M | -9.69M | -13.67M | -16.84M | -19.33M |
| EPS Basic | -11.10 | -11.56 | -18.54 | -19.47 | -21.68 |
| Normalized Basic EPS | -7.13 | -7.42 | -10.17 | -10.76 | -11.94 |
| EPS Diluted | -11.10 | -12.06 | -20.59 | -25.35 | -29.32 |
| Normalized Diluted EPS | -7.13 | -7.42 | -10.17 | -10.76 | -11.94 |
| Average Basic Shares Outstanding | 3.14M | 3.07M | 3.02M | 3.02M | 3.01M |
| Average Diluted Shares Outstanding | 3.14M | 3.07M | 3.02M | 3.02M | 3.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |